We are live on
!
Find out more
Handelsbanken Fonder Portfolio holdings
AUM
$35.1B
1-Year Est. Return
47.76%
This Fund
S&P 500
This Quarter
Est. Return
+2.36%
1 Year Est. Return
+47.76%
3 Year Est. Return
+137.96%
5 Year Est. Return
+170.36%
10 Year Est. Return
+934.7%
AUM
$26.2B
AUM Growth
+$914M
(+3.6%)
Cap. Flow
+$1.01B
Cap. Flow
% of AUM
3.87%
Top 10 Holdings %
Top 10 Hldgs %
32.55%
Holding
1,591
New
69
Increased
817
Reduced
431
Closed
49
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$107M |
| 2 |
EXL Service
EXLS
|
+$72M |
| 3 |
Apple
AAPL
|
+$64.3M |
| 4 |
Synopsys
SNPS
|
+$56.8M |
| 5 |
ServiceNow
NOW
|
+$54.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Halozyme
HALO
|
+$74.5M |
| 2 |
Vertex Pharmaceuticals
VRTX
|
+$53.5M |
| 3 |
Edwards Lifesciences
EW
|
+$45M |
| 4 |
Abbott
ABT
|
+$40.3M |
| 5 |
Rockwell Automation
ROK
|
+$39.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 37.4% |
| 2 | Healthcare | 16.63% |
| 3 | Financials | 12.04% |
| 4 | Communication Services | 9.47% |
| 5 | Industrials | 8.26% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SUM
1001
DELISTED
Summit Materials, Inc. Class A Common Stock
SUM
| $936K | ﹤0.01% |
18,500
+2,000
| +12% | +$93.5K |
|
1002
FormFactor
FORM
$10.3B
| $935K | ﹤0.01% |
21,260
+1,300
| +7% | +$55.9K |
|
1003
Biohaven
BHVN
$2.24B
| $934K | ﹤0.01% |
25,000
+4,300
| +21% | +$201K |
|
1004
Western Union
WU
$2.34B
| $932K | ﹤0.01% |
87,900
-18,900
| -18% | -$209K |
|
1005
M/I Homes
MHO
$3.9B
| $931K | ﹤0.01% |
7,000
| – | – |
|
1006
PJT Partners
PJT
$4.57B
| $931K | ﹤0.01% |
5,900
+800
| +16% | +$122K |
|
1007
Hilton Grand Vacations
HGV
$3.49B
| $927K | ﹤0.01% |
23,809
-1,600
| -6% | -$63K |
|
|
DNB
1008
DELISTED
Dun & Bradstreet
DNB
| $926K | ﹤0.01% |
74,300
+11,000
| +17% | +$132K |
|
1009
Texas Capital Bancshares
TCBI
$4.38B
| $925K | ﹤0.01% |
11,823
-900
| -7% | -$72.9K |
|
1010
C3.ai
AI
$1.58B
| $923K | ﹤0.01% |
+26,800
| New | +$832K |
|
1011
LXP Industrial Trust
LXP
$3.58B
| $919K | ﹤0.01% |
22,643
+760
| +3% | +$35.2K |
|
1012
DXC Technology
DXC
$1.79B
| $917K | ﹤0.01% |
45,900
+3,400
| +8% | +$71.7K |
|
1013
Penske Automotive Group
PAG
$14.4B
| $917K | ﹤0.01% |
6,016
-1,100
| -15% | -$175K |
|
1014
OSI Systems
OSIS
$3.77B
| $915K | ﹤0.01% |
5,465
-700
| -11% | -$111K |
|
1015
WD-40
WDFC
$3.09B
| $914K | ﹤0.01% |
3,765
+400
| +12% | +$107K |
|
1016
Sensient Technologies
SXT
$5.53B
| $908K | ﹤0.01% |
12,737
| – | – |
|
|
ROIC
1017
DELISTED
Retail Opportunity Investments Corp.
ROIC
| $906K | ﹤0.01% |
52,197
+3,600
| +7% | +$60.2K |
|
1018
Vericel Corp
VCEL
$2.28B
| $905K | ﹤0.01% |
16,479
+1,000
| +6% | +$50.6K |
|
1019
BGC Group
BGC
$5.2B
| $898K | ﹤0.01% |
99,078
+10,400
| +12% | +$100K |
|
1020
Acadia Realty Trust
AKR
$2.86B
| $895K | ﹤0.01% |
37,032
+4,100
| +12% | +$101K |
|
1021
Columbia Sportswear
COLM
$2.96B
| $895K | ﹤0.01% |
10,658
+400
| +4% | +$33.5K |
|
|
ACLX
1022
DELISTED
Arcellx
ACLX
| $890K | ﹤0.01% |
11,600
-1,000
| -8% | -$86.4K |
|
1023
Federated Hermes
FHI
$4.74B
| $890K | ﹤0.01% |
21,653
+1,400
| +7% | +$56.5K |
|
|
TPH
1024
DELISTED
Tri Pointe Homes
TPH
| $890K | ﹤0.01% |
24,555
+3,800
| +18% | +$158K |
|
1025
Xenon Pharmaceuticals
XENE
$6.21B
| $890K | ﹤0.01% |
22,700
| – | – |
|
Similar funds
GAM
Handelsbanken Fonder's Q4 2024 Portfolio in Review
As of Q4 2024, Handelsbanken Fonder held 1,591 positions worth $26.2B, up 3.6% from $25.3B the previous quarter. Its ten largest holdings account for 33% of the portfolio.
Handelsbanken Fonder deployed $1.01B of net new capital in Q4 2024, opening 69 new positions and adding to 817 existing holdings. Its largest new stake was GE Vernova: 105,537 shares worth $34.7M.
By sector, the portfolio is most concentrated in Technology at 37% of assets, up from 35% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Halozyme, an estimated $74.5M trimmed.
- Handelsbanken Fonder's largest Q4 2024 buy was GE Vernova: 105,537 shares worth $34.7M.
- Handelsbanken Fonder added most to Microsoft in Q4 2024, an estimated $107M increase.
- Handelsbanken Fonder's biggest Q4 2024 reduction was Halozyme, cutting an estimated $74.5M.
- Handelsbanken Fonder fully exited BeOne Medicines Ltd in Q4 2024, selling an estimated $5.92M.
- Handelsbanken Fonder's ten largest holdings make up 33% of its $26.2B portfolio in Q4 2024.
- Handelsbanken Fonder opened 69 new positions and closed 49 in Q4 2024.
- Handelsbanken Fonder's portfolio value rose 3.6% quarter-over-quarter to $26.2B.
Based on Handelsbanken Fonder's 13F filing for Q4 2024, filed 3 Feb 2025.